GSK Said in Talks to Sell Lucozade Drinks Unit to Suntory

GlaxoSmithKline Plc, the U.K.’s largest drugmaker, is in talks to sell its Lucozade and Ribena drink brands to Japan’s Suntory Beverage and Food Ltd., according to three people familiar with the discussions.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.